News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst upgrades FormFactor to Strong Buy, citing AI test measurement demand and $140M Texas expansion.
  • Upgrade sets entry at $110, stop $98 and a 180-day target of $160, implying significant upside.
  • FormFactor's transformation into AI and silicon photonics testing supplier highlights investor interest in chip infrastructure plays.
  • Dyne Therapeutics priced an upsized $375M stock offering at $20.50 to fund neuromuscular drug programs.
  • The Dyne deal will add 18.3 million new shares, likely increasing near-term dilution for existing holders.
  • Combined themes of AI-capex upgrades and sizable biotech fundraising point to ongoing appetite for growth equities.

Latest Articles

U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Strength Remains Unchanged

U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Strength Remains Unchanged

U.S. Global Investors announced a restatement of its earnings per share for the three- and nine-month periods ended March 31, 2026, due to an inadvertent omission affecting the weighted average shares calculation. The restatement led to a slight reduction in EPS ($0.02 for Q3 and $0.01 for nine months), but the company's net income, revenue, and as…

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8

Shattuck Labs, a clinical-stage biotech company focusing on monoclonal and bispecific DR3-blocking antibodies, will hold an investor call on June 8 to present comprehensive Phase 1 clinical data for its lead candidate SL-325. The data includes safety, pharmacokinetics, and immunogenicity results. SL-325 is a potential first-in-class treatment targe…

Liftoff Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Liftoff Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Liftoff Mobile, a leader in AI-powered performance marketing and monetization for mobile apps, completed its initial public offering (IPO) by selling 21.85 million shares at $23 per share. The underwriters fully exercised their option to purchase an additional 2.85 million shares, signaling strong market interest. Proceeds will be used to pay down …

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Structure Therapeutics shares positive Phase 2b clinical data for aleniglipron, an oral small molecule GLP-1 receptor agonist for obesity treatment, demonstrating significant and durable weight loss up to 16.2% over 36 weeks, alongside a favorable safety and tolerability profile. The data, published in Nature Medicine and presented at the American …

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jade Biosciences has successfully closed a public offering of 11.5 million shares at $15.00 each, including full exercise of the underwriters' option, raising gross proceeds of $172.5 million. The clinical-stage biotechnology company plans to use the net proceeds to advance clinical trials, preclinical studies, research, and manufacturing focused o…

Birchcliff Energy: Upgrade on an Efficiency Pivot — A Tactical Long

Birchcliff Energy: Upgrade on an Efficiency Pivot — A Tactical Long

Birchcliff Energy (BIREF) trades at $4.63 with a market cap of roughly $1.27B. With a sub-1.0 P/B, a modest dividend and elevated short interest, the stock is positioned for a mid-term rebound if management can deliver measurable efficiency gains. We upgrade to a tactical long and lay out an entry, stop and target with a 45-trading-day thesis.

House Panel Unveils Draft Tax Overhaul for Digital Assets

House Panel Unveils Draft Tax Overhaul for Digital Assets

<p>The House Ways and Means Committee released draft legislative language proposing multiple changes to how digital assets are taxed and reported. Key measures would defer income recognition for tokens produced by mining or staking until sale, treat such gains as ordinary income rather than capital gains, permit aggregated annual reporting for wide…

U.S. Officials and OpenAI Continue Talks on Possible Federal Equity Stake

U.S. Officials and OpenAI Continue Talks on Possible Federal Equity Stake

Senior White House officials and OpenAI Chief Executive Sam Altman have held ongoing discussions about a potential federal equity stake in OpenAI. The concept, first raised in 2025, would involve OpenAI donating shares to seed a sovereign investment vehicle intended to deliver long-term, diversified returns to the American public. Meetings this wee…

Options Volume in Mondelez Surges to 3,842 Contracts in Midday Session

Options Volume in Mondelez Surges to 3,842 Contracts in Midday Session

Options volume for Mondelez International Inc. climbed to 3,842 contracts as of 2:20 p.m. New York time, with calls representing 2,218 contracts and puts 1,624 contracts. Three specific strikes - a March 19, 2027 $60 put, a $62 call expiring today, and a July 17, 2026 $65 call - dominated the session's trading, according to exchange data compiled b…

US States Move to Block Paramount Skydance's $110 Billion Warner Bros Deal

US States Move to Block Paramount Skydance's $110 Billion Warner Bros Deal

A coalition of US states led by California and New York is preparing to sue to block Paramount Skydance's $110 billion acquisition of Warner Bros, with the action expected within weeks. The move signals state-level antitrust enforcement stepping forward as federal regulators pursue a more business-friendly approach. Market reaction included a drop …

UN Faults Social Media for Fanning Misinformation After Tripoli Protests

UN Faults Social Media for Fanning Misinformation After Tripoli Protests

The United Nations said it is deeply concerned after violent demonstrations outside its Tripoli offices, blaming social media for spreading disinformation about UN activities. Hundreds of protesters on Thursday blocked the UN refugee agency office, the largest in a series of recent protests targeting migrants in Libya amid prolonged conflict and ec…